Invitation Is Geared To Matching Investors With Disruptive Changes In Healthcare And Finance.
Toronto, Canada - CardioComm Solutions, Inc. ( TSX-V:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of ECG acquisition and management software solutions is pleased to announce they will present at the OneMedForum SF 2013 conference to be held January 7 to January 10, 2013, at the Sir Francis Drake Hotel in San Francisco, CA.
OneMedForum 2013 is an international healthcare conference where emerging private and small cap public companies present and meet with investors of all types including high net worth individuals, alternative investors, asset managers, hedge funds, institutional investors, and venture capitalists. Over 1,000 investors, executives, corporate strategic partners and key opinion leaders attended the 2012 Forum.
"OneMedForum SF 2013 is the definitive conference in North America for fast-growing healthcare and life sciences companies. Held during the largest gathering of healthcare investors and companies, the 6th annual OneMedForum is a meeting point for those financing and building emerging growth companies shaping the future of health and medicine," said Mr. Brett Johnson, President, CEO and Founder of OneMedPlace. "We are pleased to have CardioComm Solutions as part of our program and look forward to working with them in developing opportunities for promotion of their technologies and products."
In this year's program, Etienne Grima, CardioComm Solution's Chief Executive Officer, will be presenting to an attendee group consisting of institutional investors, strategic investors, research analysts, advisors, consultants, academics, and other industry veterans. The presentation will be recorded and the webcast made available to the public and will be archived for members of OneMedPlace. The presentation will be webcast live at the link: http://onemedplace.com/forum/webcast/.
"We were pleased to be invited to present at the 6th Annual OneMedForum as it represents a great opportunity to discuss recent developments with our HeartCheckTM Product, SMART Monitoring Software platform and to update investor groups on our business development plans for 2013," said Etienne Grima. "2012 was the year of preparation with several product clearances secured, thus paving the way for global distribution of our HeartCheckTM Products and SMART Monitoring Services in 2013. This invitation complements the Frost & Sullivan award we received as the North American 2012 Arrhythmia Monitoring Enabling Technology and confirming CardioComm Solutions as a disruptive technology innovator and prepares the path for 2013 sales, distributor and partnership deals."
Through news services, radio interviews, video production, and research, OneMedPlace specializes in delivering information to investors covering nanocap, microcap and private emerging growth companies in the hottest areas of life sciences. OneMedPlace produces a weekly newsletter and research reports covering what we believed to be an undervalued sector, and has built a network of investors at all levels of financial and strategic development. Visit www.onemedplace.com to learn more about the materials we provide to help give you a competitive advantage.
About CardioComm Solutions
CardioComm Solution's patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION ON CARDIOCOMM SOLUTIONS PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
Leave a comment...